Ownership
Private
Employees
~1700
Therapeutic Areas
Dermatology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeBiologic (for topical and dermatological use)Device (cosmetic/dermatological devices)

ISDIN General Information

ISDIN’s products are widely used globally with clinical studies supporting efficacy for several lines. Their Eryfotona Actinica sunscreen contains photolyase enzyme to aid DNA repair post-sun exposure. The Isdinceutics line includes clinically tested anti-aging serums and targeted solutions for pigmentation and eye area concerns. U.S.-specific clinical data are being developed; European product studies are available.

Contact Information

Primary Industry
Non-Drug Biotech
Corporate Office
Barcelona, Catalonia
Spain

Drug Pipeline

No pipeline data available

For full access to ISDIN's pipeline data

Book a demo

Key Partnerships

Works closely with dermatologists and pharmacists worldwide, member of various industry associations including Farma Industria Asociación Nacional Empresarial de la Industria Farmaceutica

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

ISDIN Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view ISDIN's complete valuation and funding history, request access »

ISDIN Financial Metrics